| Nome |
# |
|
Non-coding RNAs functioning in colorectal cancer stem cells, file e3ad891a-bb09-da0e-e053-3705fe0a2b96
|
1.690
|
|
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer, file e3ad891a-fee4-da0e-e053-3705fe0a2b96
|
1.674
|
|
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis, file e3ad891c-7bb9-da0e-e053-3705fe0a2b96
|
954
|
|
Male breast cancer., file e3ad8915-e4ef-da0e-e053-3705fe0a2b96
|
903
|
|
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis, file e3ad891a-4ac0-da0e-e053-3705fe0a2b96
|
840
|
|
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)., file e3ad8915-d150-da0e-e053-3705fe0a2b96
|
591
|
|
Galectin-3 in acute coronary syndrome, file e3ad891b-859a-da0e-e053-3705fe0a2b96
|
584
|
|
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?, file e3ad891d-4881-da0e-e053-3705fe0a2b96
|
548
|
|
Dietary restriction: could it be considered as speed bump on tumor progression road?, file e3ad8919-0b8f-da0e-e053-3705fe0a2b96
|
543
|
|
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment, file e3ad8915-d530-da0e-e053-3705fe0a2b96
|
540
|
|
EGFR inhibition in NSCLC: New findings…. and opened questions?, file e3ad891a-e75e-da0e-e053-3705fe0a2b96
|
538
|
|
Monoclonal antibodies in gastrointestinal cancers, file e3ad8917-5d1a-da0e-e053-3705fe0a2b96
|
511
|
|
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness., file e3ad8916-528d-da0e-e053-3705fe0a2b96
|
492
|
|
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?, file e3ad8916-d056-da0e-e053-3705fe0a2b96
|
473
|
|
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs, file e3ad891b-60d9-da0e-e053-3705fe0a2b96
|
457
|
|
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer, file e3ad8916-eedb-da0e-e053-3705fe0a2b96
|
417
|
|
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg?, file e3ad8916-6476-da0e-e053-3705fe0a2b96
|
402
|
|
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?, file e3ad891a-3209-da0e-e053-3705fe0a2b96
|
398
|
|
A headlight on liquid biopsies: a challenging tool for breast cancer management, file e3ad8919-1039-da0e-e053-3705fe0a2b96
|
392
|
|
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer?, file e3ad8916-8501-da0e-e053-3705fe0a2b96
|
368
|
|
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations, file e3ad8917-5546-da0e-e053-3705fe0a2b96
|
363
|
|
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma, file e3ad8919-b376-da0e-e053-3705fe0a2b96
|
337
|
|
Expression of angiogenic regulators, VEGF and leptin, is regulated by the
EGF/PI3K/STAT3 pathway in colorectal cancer cells., file e3ad8915-e4eb-da0e-e053-3705fe0a2b96
|
334
|
|
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions, file e3ad8916-f0ee-da0e-e053-3705fe0a2b96
|
334
|
|
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC
(RASCAL) and TP53CRC collaborative studies., file e3ad8915-d532-da0e-e053-3705fe0a2b96
|
330
|
|
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?, file e3ad8916-d383-da0e-e053-3705fe0a2b96
|
330
|
|
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma, file e3ad8915-f19c-da0e-e053-3705fe0a2b96
|
323
|
|
Breast cancer genome-wide association studies: there is strength in numbers, file e3ad891a-50e7-da0e-e053-3705fe0a2b96
|
307
|
|
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses., file e3ad8915-e52e-da0e-e053-3705fe0a2b96
|
288
|
|
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines, file e3ad8916-f0de-da0e-e053-3705fe0a2b96
|
285
|
|
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option?, file e3ad8918-4793-da0e-e053-3705fe0a2b96
|
285
|
|
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions, file e3ad8923-2872-da0e-e053-3705fe0a2b96
|
285
|
|
Anti-endothelin drugs in solid tumors, file e3ad8917-57be-da0e-e053-3705fe0a2b96
|
279
|
|
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?, file e3ad8916-d053-da0e-e053-3705fe0a2b96
|
278
|
|
Nintedanib in NSCLC: Evidence to date and place in therapy, file e3ad8919-7361-da0e-e053-3705fe0a2b96
|
263
|
|
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario, file e3ad891a-fee9-da0e-e053-3705fe0a2b96
|
257
|
|
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and
progression of pleomorphic adenomas., file e3ad891a-7fb6-da0e-e053-3705fe0a2b96
|
252
|
|
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?, file e3ad891a-6317-da0e-e053-3705fe0a2b96
|
250
|
|
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors, file e3ad8916-6b31-da0e-e053-3705fe0a2b96
|
246
|
|
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials, file e3ad8921-8325-da0e-e053-3705fe0a2b96
|
242
|
|
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis, file e3ad8919-b5e4-da0e-e053-3705fe0a2b96
|
240
|
|
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon, file e3ad8927-2701-da0e-e053-3705fe0a2b96
|
239
|
|
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients, file e3ad891e-ce8b-da0e-e053-3705fe0a2b96
|
205
|
|
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway, file e3ad891b-7d86-da0e-e053-3705fe0a2b96
|
202
|
|
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier
probability., file e3ad8915-f195-da0e-e053-3705fe0a2b96
|
199
|
|
The role of Aurora-A inhibitors in cancer therapy., file e3ad8915-e89e-da0e-e053-3705fe0a2b96
|
198
|
|
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials, file e3ad891f-81a2-da0e-e053-3705fe0a2b96
|
198
|
|
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome, file e3ad8927-7bb5-da0e-e053-3705fe0a2b96
|
198
|
|
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study., file e3ad891a-5380-da0e-e053-3705fe0a2b96
|
197
|
|
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis, file e3ad891f-ce1c-da0e-e053-3705fe0a2b96
|
196
|
|
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study, file e3ad8915-e9ab-da0e-e053-3705fe0a2b96
|
193
|
|
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE, file e3ad8917-0bae-da0e-e053-3705fe0a2b96
|
190
|
|
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus, file e3ad8919-b53d-da0e-e053-3705fe0a2b96
|
189
|
|
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin, file e3ad891b-8a11-da0e-e053-3705fe0a2b96
|
189
|
|
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?, file e3ad8916-6fe4-da0e-e053-3705fe0a2b96
|
187
|
|
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a
Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite
instability status and country of origin., file e3ad8915-dc7d-da0e-e053-3705fe0a2b96
|
182
|
|
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients, file e3ad891f-0eff-da0e-e053-3705fe0a2b96
|
182
|
|
Aberrant methylation within RUNX3 CpG island associated with the nuclear and
mitochondrial microsatellite instability in sporadic gastric cancers. Results of
a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study., file e3ad8915-d153-da0e-e053-3705fe0a2b96
|
180
|
|
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells, file e3ad8916-d6c4-da0e-e053-3705fe0a2b96
|
175
|
|
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma, file e3ad8919-9cf9-da0e-e053-3705fe0a2b96
|
175
|
|
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets, file e3ad8916-8c1b-da0e-e053-3705fe0a2b96
|
168
|
|
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications, file e3ad8923-1b38-da0e-e053-3705fe0a2b96
|
166
|
|
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC), file e3ad891d-59d1-da0e-e053-3705fe0a2b96
|
165
|
|
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS?, file e3ad8919-6933-da0e-e053-3705fe0a2b96
|
162
|
|
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis, file e3ad891e-81f0-da0e-e053-3705fe0a2b96
|
162
|
|
VUS variants in BRCA genes of hereditary breast/ovarian cancer, file e3ad8915-e9bd-da0e-e053-3705fe0a2b96
|
160
|
|
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status, file e3ad891a-7429-da0e-e053-3705fe0a2b96
|
160
|
|
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC), file e3ad8921-474a-da0e-e053-3705fe0a2b96
|
160
|
|
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients, file e3ad8925-51cb-da0e-e053-3705fe0a2b96
|
159
|
|
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study, file e3ad8915-e4f9-da0e-e053-3705fe0a2b96
|
157
|
|
Founder mutations in BRCA1 and BRCA2 genes, file e3ad8915-dc74-da0e-e053-3705fe0a2b96
|
143
|
|
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis, file e3ad8920-2855-da0e-e053-3705fe0a2b96
|
141
|
|
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy, file e3ad8917-0ae3-da0e-e053-3705fe0a2b96
|
137
|
|
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2, file e3ad8922-ee6c-da0e-e053-3705fe0a2b96
|
136
|
|
null, file e3ad891b-6cb8-da0e-e053-3705fe0a2b96
|
119
|
|
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?, file e3ad8920-902b-da0e-e053-3705fe0a2b96
|
117
|
|
Hereditary ovarian cancer, file e3ad8915-e4f2-da0e-e053-3705fe0a2b96
|
108
|
|
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma, file e3ad8916-772d-da0e-e053-3705fe0a2b96
|
105
|
|
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial, file e3ad8923-287b-da0e-e053-3705fe0a2b96
|
104
|
|
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway, file e3ad8919-4bd3-da0e-e053-3705fe0a2b96
|
98
|
|
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge, file e3ad8927-342f-da0e-e053-3705fe0a2b96
|
98
|
|
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis, file e3ad8921-9605-da0e-e053-3705fe0a2b96
|
95
|
|
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score, file e3ad8922-e4c0-da0e-e053-3705fe0a2b96
|
95
|
|
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1, file e3ad8921-ef20-da0e-e053-3705fe0a2b96
|
91
|
|
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes, file e3ad8922-de27-da0e-e053-3705fe0a2b96
|
91
|
|
Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3), file e3ad8921-fd85-da0e-e053-3705fe0a2b96
|
86
|
|
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer, file e3ad8925-5e95-da0e-e053-3705fe0a2b96
|
86
|
|
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible, file b7ea5aad-4f2d-45b8-a0e9-b5e45cdf82c1
|
80
|
|
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway, file e3ad891b-0fde-da0e-e053-3705fe0a2b96
|
77
|
|
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis, file bde11d1e-a3c7-4772-a073-473b4c78c72c
|
76
|
|
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming, file e3ad8925-4d86-da0e-e053-3705fe0a2b96
|
76
|
|
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4), file e3ad8921-ca15-da0e-e053-3705fe0a2b96
|
72
|
|
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials, file e3ad8927-4bd7-da0e-e053-3705fe0a2b96
|
70
|
|
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas, file e3ad8915-e52c-da0e-e053-3705fe0a2b96
|
62
|
|
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer, file 64bedddd-d6ef-44f3-a4a4-cee28b08ca7e
|
61
|
|
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment, file e3ad8919-0a8e-da0e-e053-3705fe0a2b96
|
59
|
|
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?, file e3ad8915-e55b-da0e-e053-3705fe0a2b96
|
58
|
|
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet?, file e3ad891b-5ebe-da0e-e053-3705fe0a2b96
|
57
|
|
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma, file e3ad8916-00ca-da0e-e053-3705fe0a2b96
|
56
|
|
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma, file e3ad8926-e916-da0e-e053-3705fe0a2b96
|
56
|
| Totale |
27.426 |